Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Research
    • Structural Heart Disease
    • TAVR
    • Therapies
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe

Search form

Home
News You Need to Know Today
News Alert: FDA approves first cellular therapy to treat type 1 diabetes
Thursday, June 29, 2023
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

News Alert

FDA approves first cellular therapy to treat type 1 diabetes

The new therapy, made from the pancreatic cells of deceased donors, is designed to help adult type 1 diabetes with severe hypoglycemia go a year or longer without needing to take insulin. 

READ MORE >
The FDA has approved donislecel, a new pancreatic islet cellular therapy made from the pancreatic cells of deceased donors, for the treatment of type 1 diabetes among adult patients with severe hypoglycemia. Lantidra
Share on Twitter Share on Facebook Share on Linkedin

FDA approves first cellular therapy to treat type 1 diabetes

Share on Twitter Share on Facebook Share on Linkedin
The FDA has approved donislecel, a new pancreatic islet cellular therapy made from the pancreatic cells of deceased donors, for the treatment of type 1 diabetes among adult patients with severe hypoglycemia. Lantidra
The new therapy, made from the pancreatic cells of deceased donors, is designed to help adult type 1 diabetes with severe hypoglycemia go a year or longer without needing to take insulin. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

AI detects AFib in asymptomatic patients | The evolving roles of TEE & ICE | Shockwave's new IVL catheter
Radial access during PAD interventions | More details on the big policy shift in carotid stenting | Heart-healthy diets
Economics: Compensation at hospitals vs. private practices | Fraud allegations settled for $85M | Will Medtronic sell?
Key approvals for Edwards & Medtronic | Looking ahead to TCT 2023 | Gene therapy for HCM | More from the last week
Care Delivery Highlights: The world's 50 best hospitals for heart surgery | One-stop cardiology clinic opens
TTVR device gains key approval | Cardiologist-founded virtual clinic raises $8M | Doc suspended for alleged support of Hamas
News Alert: New tricuspid valve replacement device gains CE mark approval

Pagination

    • First page « First
    • Previous page ‹ Previous
    • Page …11
    • Page 12
    • Page 13
    • Page 14
    • Current page 15
    • Page 16
    • Page 17
    • Page 18
    • Page 19 …
    • Next page Next ›
    • Last page Last »
  • Home
  • News
  • Sitemap
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • AI in Healthcare
  • Cardiovascular Business
  • HealthExec
  • Health Imaging
  • Radiology Business
 
© 2024 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme
Trimed Popup